Quarter Financials

Apellis Pharmaceuticals, Inc. (APLS)

$67.85

-0.93 (-1.35%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands , Years are calendar years not fiscal years

Retained Earning Schedule

Year 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4
Net Income -140-122-178-166-191-156-139-148
Dividend Paid --------
Retained Earnings -2,749-2,609-2,487-2,309-2,143-1,952-1,796-1,657

PPE Schedule

Year 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4
Capital Expenditure -0-0-0-1-0-0-0-0
Net PPE 2022242525272626

Intangible and Goodwill Schedule

Year 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4
New Purchases -0-332-332-332---
Intangible and Goodwill --------